Genetic Background of Anticyclic Citrullinated Peptide Autoantibody Production in Hungarian Patients with Rheumatoid Arthritis
- 1 September 2007
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1110 (1) , 23-32
- https://doi.org/10.1196/annals.1423.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewAnnals of the Rheumatic Diseases, 2006
- The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritisArthritis & Rheumatism, 2006
- Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case–control studyArthritis Research & Therapy, 2006
- A functional haplotype of thePADI4gene associated with increased rheumatoid arthritis susceptibility in KoreansArthritis & Rheumatism, 2005
- Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteinsArthritis & Rheumatism, 2005
- Association between PADI4 and rheumatoid arthritis: A replication studyArthritis & Rheumatism, 2005
- PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish populationRheumatology, 2005
- A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French populationAnnals of the Rheumatic Diseases, 2005
- Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severityArthritis Research & Therapy, 2005
- Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritisNature Genetics, 2003